Archive for May, 2012

Major UK Sainsbury’s wanted to ensure its key propositions: Live Well for Less, By Sainsbury’s and Brand Match were firmly established into the mind of the consumer, and to form a steadfast association of Sainsbury’s with both ‘value’ and ‘quality’. For this campaign, Sainsbury’s broad target audience was women aged over 25, with a focus on those of social grades C2,D,E with Kids.

The Solution: The campaign created was an integrated content solution, to drive the partnership between Sainsbury’s, media agency PHD and MSN UK resulted in the creation of “Food” – a bespoke content channel within MSN’s Life and Style section. “Food” provided MSN visitors with bespoke culinary-related content, produced by MSN’s

 8360.Sainsbury500 Microsoft Advertising drives brand favourability up 14% points for major UK supermarket

Editorial experts, within an environment sponsored by Sainsbury’s, and promoting Sainsbury’s grocery propositions via features, advertorials, polls and competitions. Visit http://food.uk.msn.com/

To generate awareness, large broadcast formats like Homepage Takeovers and Portal Takeovers were used, plus additional branded display MPU’s were targeted to Women 25+ across the Microsoft Advertising network including Mobile.

The results – Reach & Frequency: Overall, the campaign reached 9.5m UK adults, or 23% of the UK online population. The average frequency was 12, equivalent to 274.2 Online GRP’s. Reach within Women 25+ was 27% (Index 121) rising to 33% amongst C2DE Women 25+ with kids (Index 144).

The results – Driving Action: In terms of driving action, overall, the campaign delivered

  • A 15% uplift in visits to sainsburys.co.uk/groceries (versus control).
  • This increased to 22% uplift amongst Women 25+ and 60% uplift amongst C2DE Women 25+ with kids
  • 69% of visitors to sainsburys.co.uk/groceries, who had seen the campaign, were women.

The results – Driving Brand: Brand Favourability increased +14 percentage points amongst Women 25+ `Brand Recommendation increased +19 percentage points amongst C2DE Women 25+ with kids.

1273.module 5F00 QueensJubilee 5F00 thumb 5F00 3080128E Microsoft Advertising drives brand favourability up 14% points for major UK supermarket3817.EatingIn 5F00 wine 5F00 thumb 5F00 343DB75E Microsoft Advertising drives brand favourability up 14% points for major UK supermarket2248.XmasCanapes 5F00 cookbooksfeature 5F00 thumb 5F00 37FB5C2E Microsoft Advertising drives brand favourability up 14% points for major UK supermarket

“Using MSN’s editorial talent to showcase our key message of ‘Live Well for Less’ with relevant content, combined with effective targeting of our audiences, resulted in an engaging and measurably successful partnership between Sainsbury’s and MSN.”  Adrian Barragan, Senior Digital Brand Manager, J Sainsbury PLC.

Thanks for reading!

Leena (@LeenaShahUK)

 Microsoft Advertising drives brand favourability up 14% points for major UK supermarket

Over 2 million AdSense publishers like you create the unique and diverse content that we all love – whether it’s finding reviews for a new restaurant, or do-it-yourself furniture makeovers. Online advertising helps fuel this creativity, and we’ve been improving our products to help you make the most of every opportunity – from making it easier to earn revenue from the mobile web, or welcoming Indonesian publishers to the AdSense community.  One of the ways we can continue to support you is by giving access to new sources of industry knowledge to enable you to make the most from display advertising. With this is mind, today we’re introducing a new report, “Display Business Trends: Publisher Edition”.

What’s inside for AdSense publishers? Well for starters, there are answers to questions like:

  • Which ad sizes are rising in popularity? You control the ad experience on your site by choosing ad sizes that fit the design of your pages. But with such a flexible selection, which ad sizes should you pick? We found that 80% of all ads served tend to be the three best performing ad units for AdSense publishers: the medium rectangle, leaderboard, and skyscraper. We’re also seeing fewer publishers use smaller ad units, like the 468×60 banner.
  • Is the mobile web really a big deal? We think so! We saw a 250% increase in mobile web impressions over the last three months of 2011. Growth in mobile usage has exploded, and there’s never been a better time for your site to go mobile. Check out resources for publishers on our GoMo site and Mobile Mondays blogposts.
  • Which sites are showing strong impression growth? In 2011, we found that Shopping, Sports, and Auto & Vehicle sites were some of the fastest year-on-year growth verticals on the Ad Exchange and AdSense. We saw impressive figures across the board, with 15 out of 25 publisher verticals displaying double-digit growth.
  • Where in the world are you? All over, as it turns out. Of a possible estimated 245 different countries and territories, we saw publisher ad impressions from 235 of them. These included the island country of Palau – one of the world’s newest sovereign states – and the middle-African nation of Equatorial Guinea, with astounding growth rates of 1106% and 4635% respectively. And while the United States still accounts for the highest percentage of impressions overall, we’re seeing a significant representation from China and Japan, coming in at 11% and 6% respectively.
world map 02 New industry metrics to help publishers make the most from the web

The Publisher Edition will be the first in a series of publications looking at aggregated global data from across Google’s display advertising solutions, so stay tuned for more industry metrics to come. In the meantime, join the conversation and tell us what you think is behind these trends on our AdSense +Page.
Posted by Mel Ann Chan, Product Marketing Manager, Display Advertising
5576995 5717276098210346575?l=adsense.blogspot New industry metrics to help publishers make the most from the web
 New industry metrics to help publishers make the most from the web

 New industry metrics to help publishers make the most from the web

Recently MCR American Pharmaceuticals debuted a new cold fighting remedy called Congestinex C that aims to relieve flu like symptoms.
 

The newest MCR American Pharmaceuticals product called Congestinex C was released two weeks ago and is marketed directly to medical professionals and the general public.

Congestinex C is an antihistamine, available in grape flavor and is recommended for patients who have post-nasal drip cough. Congestinex C can help calm a runny nose and may stop sneezing.

For the most part, FDA experts do not recommend young children consume cold-fighting over-the-counter medications, yet Congestinex C is safe for those older than age two. MCR American Pharmaceuticals designed Congestinex C to suit young children by using lower doses of Chlorpheniramine, and Dextromethorphan.

“We created Congestinex C to relieve cold and flu-like symptoms for even the youngest of our patients,” said David Ambrose, an executive at MCR American Pharmaceuticals.

Since MCR American Pharmaceuticals sells its medications directly to medical professionals and consumers, patients receive the medications at a reduced price. Rather than work with a middleman, MCR American Pharmaceuticals works directly with its customers, thus the company removes the unnecessary costs of paying a distributor and is able to sell its own products at a more affordable price.

“This is a win-win situation for everyone,” said David Ambrose. “Doctors receive their medications faster and patients receive cheaper medications.”

MCR American Pharmaceuticals manufactures other cold-fighting product families such as Maxiphen, Maxifed and Super-Tuss. Each medication group consists of products that are sold on the company’s Web site and aim to relieve patients from colds and flu-like symptoms.

“MCR American Pharmaceuticals is dedicated to providing individuals with self medication products for in-home treatment and prevention of medical conditions and ailments,” David Ambrose said. “We continuously strive to manufacture products that really make a difference.”

More About MCR American Pharmaceuticals
Brooksville-based specialty pharmaceutical company MCR American Pharmaceuticals is focused on the marketing and development of the highest quality pharmaceuticals. MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, AL. and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by David Ambrose and was relocated to Brooksville, FL. and in 2008 the company was acquired by Neuro-HiTech. Today MCR American Pharmaceuticals’ products are marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and local pharmacies.

3248018107635893461 7516523084000303242?l=web pr.blogspot A New MCR American Pharmaceuticals Medication Hits the Shelves

MCR American Pharmaceuticals recently began selling a new congestion relieving medication called Congestinex PE that relieves common cold symptoms.

MCR American Pharmaceuticals officially debuted its latest cold-fighting medication called Congestinex PE, an antitussive, expectorant and decongestant. The product was announced two weeks ago and is marketed to medical professionals and consumers on the company’s Web site.

Congestinex PE, which arrives in four-ounce bottles, relieves symptoms due to common cold, hay fever or other respiratory allergies. Congestinex PE arrives in grape flavor and is suitable for ages six and older.

MCR American Pharmaceuticals explains the benefits to such medication is the low dose of Dextromethorphan, Guaifenesin, and Phenylepherine. The low dosage of such ingredients ensures the medication is suitable for young ages and is safe to consume.

“The milligram strength in the product makes the medications suitable for a range of patients,” said David Ambrose, an executive at MCR American Pharmaceuticals. “MCR American Pharmaceuticals manufactured this product to help relieve the common cold symptoms that can really drain patients.”

MCR American Pharmaceuticals manufactures other cold-fighting medication groups called Maxiphen, Maxifed and Super-Tuss. Each medication group consists of products that are sold on the company’s Web site and aim to relieve patients from colds and flu-like symptoms.

“MCR American Pharmaceuticals offers a wide variety of products that work to relieve patients of the common cold, sinusitis, hay fever and allergic rhinitis,” David Ambrose said.

More About MCR American Pharmaceuticals
MCR American Pharmaceuticals is a specialty pharmaceutical company focused on the marketing, development, sales and distribution of the highest quality pharmaceuticals. MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, AL and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by David Ambrose and was relocated to Brooksville, FL and in 2008, MCR American Pharmaceuticals was acquired by Neuro-HiTech. Today MCR American Pharmaceuticals’ products are marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and local pharmacies.

3248018107635893461 4785457087445793530?l=web pr.blogspot MCR American Pharmaceuticals Manufactures Congestinex PE

MCR American Pharmaceuticals recently began selling a new congestion relieving medication called Congestinex PE that relieves common cold symptoms.

MCR American Pharmaceuticals officially debuted its latest cold-fighting medication called Congestinex PE, an antitussive, expectorant and decongestant. The product was announced two weeks ago and is marketed to medical professionals and consumers on the company’s Web site.

Congestinex PE, which arrives in four-ounce bottles, relieves symptoms due to common cold, hay fever or other respiratory allergies. Congestinex PE arrives in grape flavor and is suitable for ages six and older.

MCR American Pharmaceuticals explains the benefits to such medication is the low dose of Dextromethorphan, Guaifenesin, and Phenylepherine. The low dosage of such ingredients ensures the medication is suitable for young ages and is safe to consume.

“The milligram strength in the product makes the medications suitable for a range of patients,” said David Ambrose, an executive at MCR American Pharmaceuticals. “MCR American Pharmaceuticals manufactured this product to help relieve the common cold symptoms that can really drain patients.”

MCR American Pharmaceuticals manufactures other cold-fighting medication groups called Maxiphen, Maxifed and Super-Tuss. Each medication group consists of products that are sold on the company’s Web site and aim to relieve patients from colds and flu-like symptoms.

“MCR American Pharmaceuticals offers a wide variety of products that work to relieve patients of the common cold, sinusitis, hay fever and allergic rhinitis,” David Ambrose said.

More About MCR American Pharmaceuticals
MCR American Pharmaceuticals is a specialty pharmaceutical company focused on the marketing, development, sales and distribution of the highest quality pharmaceuticals. MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, AL and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by David Ambrose and was relocated to Brooksville, FL and in 2008, MCR American Pharmaceuticals was acquired by Neuro-HiTech. Today MCR American Pharmaceuticals’ products are marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and local pharmacies.

3248018107635893461 4785457087445793530?l=web pr.blogspot MCR American Pharmaceuticals Manufactures Congestinex PE